Study guide

Ocular syphilis and tuberculosis

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Ocular syphilis and tuberculosis

Key Takeaways Explain This Topic AI

Ocular syphilis requires the neurosyphilis treatment pathway even when isolated ocular disease does not require pretreatment lumbar puncture.

A positive TB exposure test alone does not establish active ocular tuberculosis.

Integrate phenotype, exposure, systemic findings and microbiological evidence with infectious-disease specialists.

Last updated: October 2026

Ocular Syphilis: "The Great Mimicker"

Ocular syphilis is caused by the spirochete Treponema pallidum . It can arise at any stage of syphilitic infection (primary, secondary, latent, or tertiary) and has earned the title of "The Great Mimicker" due to its ability to imitate virtually any known clinical pattern of anterior, intermediate, posterior, or panuveitis.

Clinical Spectrum

Anterior Segment: Interstitial keratitis (deep stromal vascularization with "salmon patches" and ghost vessels), granulomatous anterior uveitis, and iris roseola (dilated, hyperaemic vascular tufts on the iris sphincter, highly suggestive of secondary syphilis).

Posterior Segment:

Acute Syphilitic Posterior Placoid Chorioretinitis (ASPPC): characteristic placoid, circular or oval, yellowish-white outer retinal/RPE lesions located in the macula or juxtapapillary area, demonstrating a characteristic granular fade in the center with hyperfluorescent borders on fluorescein angiography and disruption of the ellipsoid zone on SD-OCT.

Retinal Vasculitis: Severe, occlusive retinal arteriolitis or phlebitis with vitreous haemorrhage and exudation.

Neuroretinitis & Optic Nerve Disease: Papillitis, optic perineuritis (sheath inflammation with intact central visual acuity and peripheral field constriction), and neuroretinitis with a complete macular star.

Laboratory Diagnostics

Dual serological testing is mandatory:

Treponemal Serological Tests (EIA, CLIA, TPHA, TPPA, FTA-ABS): Detect antibodies directed against specific T. pallidum antigens. Highly sensitive and specific; usually remain positive long-term regardless of past treatment. A negative result lowers the likelihood, but early infection, immune status and assay limitations matter. With a strong compatible history or phenotype, coordinate repeat or alternative testing rather than treating one negative result as definitive exclusion.

Non-Treponemal Serological Tests (VDRL, RPR): Detect antibodies to cardiolipin-lecithin-cholesterol antigens. Quantified as a titer; reflects active, ongoing disease and tracks treatment response (a 4-fold decrease in titer indicates successful cure). Can be falsely negative in late neurosyphilis, early primary infection, or due to the prozone phenomenon (antibody excess in secondary syphilis causing false-negative un-diluted testing).

Important

Ocular syphilis is treated as neurosyphilis even with normal CSF. CDC recommends aqueous crystalline penicillin G 18–24 million units/day intravenously for 10–14 days. Confirm allergy, HIV status and follow-up with infectious-disease care. CSF evaluation is required with cranial-nerve dysfunction or other neurological findings; it is unnecessary before treatment in isolated ocular symptoms with reactive serology and confirmed ocular abnormalities. Steroid adjuncts are sometimes used, but benefit and prevention of Jarisch–Herxheimer worsening have not been proven. See CDC guidance .

Ocular Tuberculosis

Ocular tuberculosis is caused by Mycobacterium tuberculosis , an acid-fast bacillus. Intraocular disease may result from active hematogenous dissemination from an extraocular site or from a delayed-type hypersensitivity (Type IV) response to circulating mycobacterial antigens in an individual with latent infection.

Clinical Manifestations

Granulomatous Panuveitis: Indolent, chronic panuveitis with mutton-fat KPs, Koeppe/Busacca iris nodules, and broad-based posterior synechiae.

Choroidal Manifestations:

Choroidal Tubercles: Small, multiple, greyish-white or pale yellow, circumscribed nodules (typically 0.5 to 1.5 mm) located in the posterior pole; characteristic of acute hematogenous miliary tuberculosis.

Solitary Choroidal Tuberculoma: A large, elevated, yellowish subretinal mass often exceeding 4 mm in thickness, accompanied by exudative retinal detachment; mimics an amelanotic choroidal melanoma or metastatic carcinoma.

Tuberculous Serpiginous-Like Choroiditis (TB-SLC): Multifocal, non-contiguous, yellowish-white choroidal lesions with active amoeboid creeping edges and central pigmented atrophic clearing. Unlike classical autoimmune serpiginous choroidopathy (which originates at the peripapillary margin and progresses continuously), TB-SLC is multifocal, can arise anywhere in the posterior pole, and frequently involves the vitreous with prominent cells.

Retinal Vasculitis & Eales Disease Phenotype: Severe, obliterative retinal periphlebitis characterized by heavy vascular sheathing, extensive peripheral capillary non-perfusion, secondary retinal neovascularisation elsewhere (NVE), and recurrent vitreous haemorrhage.

Diagnostic Approach and Anti-Tubercular Therapy (ATT)

Investigations: High-resolution chest CT (evaluates apical scarring, calcified Ghon complexes, and lymphadenopathy); Interferon-Gamma Release Assay (IGRA: QuantiFERON-TB Gold) provides high specificity unconfounded by prior BCG vaccination; positive Tuberculin Skin Test (TST / Mantoux induration ≥ 10 mm \ge 10\text{ mm} ≥ 10 mm in immunocompetent or ≥ 5 mm \ge 5\text{ mm} ≥ 5 mm in immunocompromised); PCR of aqueous/vitreous for the IS6110 insertion sequence.

Treatment Protocol:

Standard Multi-Drug ATT: Intensive phase comprising four drugs for 2 months : Rifampicin (RIF), Isoniazid (INH), Pyrazinamide (PZA), and Ethambutol (EMB). Followed by a continuation phase comprising two drugs for 4 to 7 months : Rifampicin and Isoniazid (total treatment duration: 6 to 9 months).

Pyridoxine (Vitamin B6, 25 – 50 mg/day 25\text{--}50\text{ mg/day} 25 – 50 mg/day ) co-administered with INH to prevent peripheral neuropathy.

Systemic Corticosteroids: Oral prednisolone ( 0.5 – 1.0 mg/kg/day 0.5\text{--}1.0\text{ mg/kg/day} 0.5 – 1.0 mg/kg/day ) introduced exclusively under full ATT coverage to control destructive tissue hypersensitivity.

Treatment Boundaries in Toxoplasmosis and Necrotising Retinitis

Small peripheral toxoplasma lesions in immunocompetent patients may be observed in selected circumstances; location, size, immune status and visual threat guide antimicrobial treatment. Corticosteroids, when used, require appropriate antimicrobial coverage and specialist timing. A negative IgG can be misleading early or in immune compromise. For ARN, begin antiviral therapy promptly, obtain supportive PCR without waiting for it, adjust systemic treatment to renal function and assess the fellow eye. Preventive laser or early vitrectomy is considered individually; evidence does not establish compulsory 360-degree laser for every eye. PORN typically has rapid outer-retinal involvement and little inflammation in severe immunosuppression, but inflammation need not be completely absent. Coordinate HIV and immune-restoration care.